Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

100 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
Didier R, Morice MC, Barragan P, Noryani AAL, Noor HA, Majwal T, Hovasse T, Castellant P, Schneeberger M, Maillard L, Bressolette E, Wojcik J, Delarche N, Blanchard D, Jouve B, Ormezzano O, Paganelli F, Levy G, Sainsous J, Carrie D, Furber A, Berlan J, Darremont O, Le Breton H, Lyuycx-Bore A, Gommeaux A, Cassat C, Kermarrec A, Cazaux P, Druelles P, Dauphin R, Armengaud J, Dupouy P, Champagnac D, Ohlmann P, Ben Amer H, Kiss RG, Ungi I, Gilard M. Didier R, et al. Among authors: dupouy p. JACC Cardiovasc Interv. 2017 Jun 26;10(12):1202-1210. doi: 10.1016/j.jcin.2017.03.049. JACC Cardiovasc Interv. 2017. PMID: 28641840 Free article. Clinical Trial.
French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
Angioi M, Barragan P, Cattan S, Collet F, Dupouy P, Durand P, Fajadet J, Finet G, Gerardin B, Gommeaux A, Karsenty B, Loubeyre C, Meyer P, Morice MC, Moulichon MÉ, Sayah S, Silvestri M, Tabone X, Unterseeh T, Wittenberg O, Lablanche JM. Angioi M, et al. Among authors: dupouy p. Arch Cardiovasc Dis. 2012 Feb;105(2):60-7. doi: 10.1016/j.acvd.2011.12.003. Epub 2012 Feb 19. Arch Cardiovasc Dis. 2012. PMID: 22424323 Free article.
Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography: insights from a large French multicenter fractional flow reserve registry.
Van Belle E, Rioufol G, Pouillot C, Cuisset T, Bougrini K, Teiger E, Champagne S, Belle L, Barreau D, Hanssen M, Besnard C, Dauphin R, Dallongeville J, El Hahi Y, Sideris G, Bretelle C, Lhoest N, Barnay P, Leborgne L, Dupouy P; Investigators of the Registre Français de la FFR–R3F. Van Belle E, et al. Among authors: dupouy p. Circulation. 2014 Jan 14;129(2):173-85. doi: 10.1161/CIRCULATIONAHA.113.006646. Epub 2013 Nov 19. Circulation. 2014. PMID: 24255062
Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
Rangé G, Yayehd K, Belle L, Thuaire C, Richard P, Cazaux P, Barbou F, Köning R, Chassaing S, Teiger E, Berthier R, Decomis MP, Claudel JP, Delarche N, Brunel P, De Poli F, Dupouy P, Beygui F, Albert F, Collet JP, Montalescot G; VERIFRENCHY investigators. Rangé G, et al. Among authors: dupouy p. Arch Cardiovasc Dis. 2014 Apr;107(4):225-35. doi: 10.1016/j.acvd.2014.03.004. Epub 2014 Apr 29. Arch Cardiovasc Dis. 2014. PMID: 24794216 Free article.
6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial.
Gilard M, Barragan P, Noryani AAL, Noor HA, Majwal T, Hovasse T, Castellant P, Schneeberger M, Maillard L, Bressolette E, Wojcik J, Delarche N, Blanchard D, Jouve B, Ormezzano O, Paganelli F, Levy G, Sainsous J, Carrie D, Furber A, Berland J, Darremont O, Le Breton H, Lyuycx-Bore A, Gommeaux A, Cassat C, Kermarrec A, Cazaux P, Druelles P, Dauphin R, Armengaud J, Dupouy P, Champagnac D, Ohlmann P, Endresen K, Benamer H, Kiss RG, Ungi I, Boschat J, Morice MC. Gilard M, et al. Among authors: dupouy p. J Am Coll Cardiol. 2015 Mar 3;65(8):777-786. doi: 10.1016/j.jacc.2014.11.008. Epub 2014 Nov 16. J Am Coll Cardiol. 2015. PMID: 25461690 Free article. Clinical Trial.
France: coronary and structural heart interventions from 2010 to 2015.
Motreff P, Lattuca B, Benamer H, Guerin P, Commeau P, Cayla G, Dupouy P, Monsegu J, Derimay F, Blanchard D, Puymirat E, Auffret V, Le Breton H, Koning R. Motreff P, et al. Among authors: dupouy p. EuroIntervention. 2017 May 15;13(Z):Z25-Z31. doi: 10.4244/EIJ-D-16-00824. EuroIntervention. 2017. PMID: 28504226 Free article.
Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice).
Van Belle E, Baptista SB, Raposo L, Henderson J, Rioufol G, Santos L, Pouillot C, Ramos R, Cuisset T, Calé R, Teiger E, Jorge E, Belle L, Machado C, Barreau D, Costa M, Hanssen M, Oliveira E, Besnard C, Costa J, Dallongeville J, Pipa J, Sideris G, Fonseca N, Bretelle C, Guardado J, Lhoest N, Silva B, Barnay P, Sousa MJ, Leborgne L, Silva JC, Vincent F, Rodrigues A, Seca L, Fernandes R, Dupouy P; PRIME-FFR Study Group. Van Belle E, et al. Among authors: dupouy p. Circ Cardiovasc Interv. 2017 Jun;10(6):e004296. doi: 10.1161/CIRCINTERVENTIONS.116.004296. Circ Cardiovasc Interv. 2017. PMID: 28615234
100 results